| A living WHO guideline on drugs for covid-19 A Agarwal, B Rochwerg, F Lamontagne, RAC Siemieniuk, T Agoritsas, ... | 966 | 2022 |
| Virology, transmission, and pathogenesis of SARS-CoV-2 M Cevik, K Kuppalli, J Kindrachuk, M Peiris bmj 371, 2020 | 927 | 2020 |
| Lemierre's syndrome due to Fusobacterium necrophorum K Kuppalli, D Livorsi, NJ Talati, M Osborn The Lancet infectious diseases 12 (10), 808-815, 2012 | 294 | 2012 |
| Spectrum of CNS disease caused by rapidly growing mycobacteria NJ Talati, N Rouphael, K Kuppalli, C Franco-Paredes The Lancet infectious diseases 8 (6), 390-398, 2008 | 74 | 2008 |
| A glimpse into the eye of the COVID-19 cytokine storm K Kuppalli, AL Rasmussen EBioMedicine 55, 2020 | 66 | 2020 |
| Neurological and psychiatric presentations associated with human monkeypox virus infection: a systematic review and meta-analysis JB Badenoch, I Conti, ER Rengasamy, CJ Watson, M Butler, Z Hussain, ... EClinicalMedicine 52, 2022 | 63 | 2022 |
| India's COVID-19 crisis: a call for international action K Kuppalli, P Gala, K Cherabuddi, SP Kalantri, M Mohanan, B Mukherjee, ... The Lancet 397 (10290), 2132-2135, 2021 | 63 | 2021 |
| New nomenclature for mpox (monkeypox) and monkeypox virus clades D Ulaeto, A Agafonov, J Burchfield, L Carter, C Happi, R Jakob, ... The Lancet Infectious Diseases 23 (3), 273-275, 2023 | 55 | 2023 |
| The UK needs a sustainable strategy for COVID-19 D Gurdasani, L Bear, D Bogaert, RA Burgess, R Busse, R Cacciola, ... The Lancet 396 (10265), 1800-1801, 2020 | 33 | 2020 |
| Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ 371: m3862 M Cevik, K Kuppalli, J Kindrachuk, M Peiris Retrieved 2021-05-24, from https://www. bmj. com/content/371/bmj. m3862 doi …, 2020 | 33 | 2020 |
| Gender disparities in coronavirus disease 2019 clinical trial leadership M Cevik, SA Haque, J Manne-Goehler, K Kuppalli, PE Sax, MS Majumder, ... Clinical Microbiology and Infection 27 (7), 1007-1010, 2021 | 32 | 2021 |
| Cultural competence and humility in infectious diseases clinical practice and research SA Hussen, K Kuppalli, J Castillo-Mancilla, R Bedimo, N Fadul, I Ofotokun The Journal of infectious diseases 222 (Supplement_6), S535-S542, 2020 | 16 | 2020 |
| COVID-19 vaccine acceptance: we need to start now K Kuppalli, DM Brett-Major, TC Smith Open Forum Infectious Diseases 8 (2), ofaa658, 2021 | 13 | 2021 |
| Appropriate usage of face masks to prevent SARS-CoV-2: Sharpening the messaging amid the COVID-19 pandemic K Escandón, GP Martin, K Kuppalli, K Escandón Disaster Medicine and Public Health Preparedness 15 (4), e5-e7, 2021 | 7 | 2021 |
| Gender disparities in international COVID-19 clinical trial leadership M Cevik, SA Haque, J Manne-Goehler, K Kuppalli, PE Sax, MS Majumder, ... medRxiv, 2020.08. 02.20166751, 2020 | 4 | 2020 |
| Mpox in children and adolescents during multicountry outbreak, 2022–2023 A Hoxha, SM Kerr, H Laurenson-Schafer, N Sklenovská, BB Mirembe, ... Emerging Infectious Diseases 29 (10), 2125, 2023 | 3 | 2023 |
| Emergency committee recommendations on mpox–what’s next? RF Lewis, K Kuppalli, A Hoxha, MC Doherty Bulletin of the World Health Organization 101 (5), 300, 2023 | 3 | 2023 |
| Towards a coordinated strategy for intercepting human disease emergence in Africa KM Forbes, O Anzala, CJ Carlson, AA Kelvin, K Kuppalli, EM Leroy, ... The Lancet Microbe 2 (2), e51-e52, 2021 | 3 | 2021 |
| Successful treatment of SARS-CoV-2 in an immunocompromised patient with persistent infection for 245 days: A case report V Overbeck, BP Taylor, J Turcinovic, X Qiu, B Schaeffer, S Seitz, SR Curry, ... Heliyon 10 (1), 2024 | 2 | 2024 |
| Hostility Unmasked: Scientists on the Frontlines of the COVID-19 Pandemic K Kuppalli Clinical Infectious Diseases 78 (5), 1097-1098, 2024 | | 2024 |
